Mangoceuticals (MGRX) News Today $1.69 +0.05 (+3.05%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.69 +0.00 (+0.06%) As of 05/23/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Mangoceuticals, Inc. Terminates Agreements with Key PartnersMay 23 at 5:55 PM | tipranks.comMangoceuticals Enters Wellness Pouch Market, Appoints Tim Corkum To Lead New UnitApril 27, 2025 | nasdaq.comMangoceuticals enters into agreement to acquire assets of Smokeless TechnologyApril 27, 2025 | markets.businessinsider.comMangoceuticals Acquires IP to Expand Product LineApril 25, 2025 | tipranks.comMangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch DivisionApril 25, 2025 | globenewswire.comMangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness SolutionsApril 24, 2025 | finance.yahoo.comMangoceuticals Issues Bonus Shares to LeadershipApril 11, 2025 | tipranks.comMangoceuticals Issues Common Stock in Exchange for PreferredMarch 30, 2025 | investing.comMangoceuticals Announces Equity and Leadership ChangesMarch 21, 2025 | uk.investing.comMangoceuticals, Inc. Approves Key Amendments at Special MeetingMarch 19, 2025 | tipranks.comMangoceuticals launches PeachesRx women’s telehealth brandFebruary 21, 2025 | markets.businessinsider.comMangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss TreatmentsFebruary 20, 2025 | uk.finance.yahoo.comMangoceuticals Advances Research on Respiratory Illness Prevention Technologies Targeting Avian InfluenzaFebruary 14, 2025 | nasdaq.comMangoceuticals advances research on patented respiratory illness technologyFebruary 12, 2025 | markets.businessinsider.comMangoceuticals targets avian flu with water-based solutionFebruary 12, 2025 | msn.comMangoceuticals Expands COO Role and Increases CompensationFebruary 7, 2025 | tipranks.comMangoceuticals advances H1N1 study conducted by VipragenFebruary 6, 2025 | markets.businessinsider.comMangoceuticals advances in H1N1 and H5N1 studiesFebruary 6, 2025 | msn.comMangoceuticals executes exclusive distribution agreement with PropreFebruary 4, 2025 | markets.businessinsider.comMangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting HyperpigmentationFebruary 3, 2025 | globenewswire.comMangoceuticals, Inc. Finalizes Debt Conversion and AppointmentsJanuary 21, 2025 | tipranks.comMangoceuticals Expands with Patent Acquisition in NutraceuticalsDecember 20, 2024 | markets.businessinsider.comMangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations PatentDecember 19, 2024 | globenewswire.comMangoceuticals, Inc. (MGRX) Latest Stock News & Headlines - Yahoo FinanceDecember 6, 2024 | finance.yahoo.comMangoceuticals initiates investigation into potential stock manipulationDecember 5, 2024 | markets.businessinsider.comMangoceuticals Signs Consulting Deal with CFO JohnstonNovember 14, 2024 | markets.businessinsider.comMangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price RequirementNovember 1, 2024 | markets.businessinsider.comMangoceuticals, Inc. (MGRX) Stock Price, News, Quote & History - Yahoo FinanceOctober 26, 2024 | ca.finance.yahoo.comMangoceuticals board initiates process to evaluate strategic alternativesOctober 22, 2024 | markets.businessinsider.comMangoceuticals, Inc.: MangoRx Responds to and Refutes Recent Claims Made by Eli LillyOctober 22, 2024 | finanznachrichten.deMangoceuticals Defends Against Eli Lilly AllegationsOctober 22, 2024 | markets.businessinsider.comMangoceuticals refutes claims made by Lilly in weight-loss drug lawsuitOctober 22, 2024 | seekingalpha.comMangoRx Announces Formation of Strategy and Alternatives CommitteeOctober 22, 2024 | finance.yahoo.comMangoceuticals Opts For Strategic AlternativesOctober 22, 2024 | markets.businessinsider.comMangoRx Responds to and Refutes Recent Claims Made by Eli LillyOctober 21, 2024 | globenewswire.comStock Splits Do Matter and Here's What's Coming NextOctober 16, 2024 | 247wallst.comMangoceuticals announces 1-for-15 reverse stock splitOctober 13, 2024 | finance.yahoo.comMANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLANOctober 11, 2024 | finance.yahoo.comMANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLANOctober 11, 2024 | globenewswire.comMangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss SolutionsOctober 3, 2024 | globenewswire.comShares of Healthcare Company Rise Following Product Availability AnnouncementOctober 1, 2024 | msn.comHealthcare Shares Rise Following Product Availability AnnouncementOctober 1, 2024 | theglobeandmail.comMangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss TreatmentOctober 1, 2024 | finance.yahoo.comMangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss TreatmentOctober 1, 2024 | globenewswire.comMangoceuticals Second Quarter 2024 Earnings: US$0.092 loss per share (vs US$0.14 loss in 2Q 2023)August 18, 2024 | finance.yahoo.comMangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024August 15, 2024 | globenewswire.comMangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology PatentAugust 14, 2024 | markets.businessinsider.comMangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and TirzepatideAugust 9, 2024 | globenewswire.comMangoceuticals: MangoRx Receives Request for Proposal From ISFLST for New Male Enhancement Product Exclusive for the Asian MarketAugust 8, 2024 | finanznachrichten.deMangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention TechnologyJuly 24, 2024 | globenewswire.com Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address MGRX Media Mentions By Week MGRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGRX News Sentiment▼1.400.77▲Average Medical News Sentiment MGRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGRX Articles This Week▼11▲MGRX Articles Average Week Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MRAI News ENZ News BRTX News OTRK News SSY News BGLC News ACON News ATIP News VSEE News NIVF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGRX) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
